更年期及绝经激素治疗对免疫系统的影响

doi:10.6040/j.issn.1671-7554.0.2018.1382

摘要/Abstract

摘要： 卵巢功能衰退是女性衰老的突出表现,女性将经历月经改变直至绝经,并伴随多种绝经相关症状。绝经不仅会对心血管、骨骼、认知产生持续不良影响,而且还会导致免疫系统发生各种变化。研究表明雌激素可以调节体液免疫和细胞免疫,雌激素含量和功能的失调可以导致免疫功能紊乱。绝经激素治疗不仅可以改善更年期相关症状,还可以改善卵巢激素缺乏相关的免疫衰老,增强正常衰老机体的免疫功能,提高更年期女性的生活质量。

关键词: 更年期, 绝经, 绝经激素治疗, 免疫系统, 影响

Abstract: Ovarian dysfunction is a prominent manifestation of female aging. Women will experience menstrual changes until menopause, accompanied by a variety of menopausal-related symptoms. Menopause not only has a persistent adverse effect on cardiovascular, skeletal and cognitive functions, but also leads to various changes in the immune system. Studies have shown that estrogen can regulate humoral and cellular immunity, and the imbalance of estrogen content and function can lead to immune dysfunction. Menopausal hormone therapy can not only improve menopausal-related symptoms, but also improve ovarian hormone deficiency-related immune aging, enhance the immune function of normal aging women, and improve the quality of life of menopausal women.

Key words: Climacteric, Menopause, Menopausal hormone therapy, Immune system, Effect

中图分类号:

R711.75

石玉华,郑庆梅. 更年期及绝经激素治疗对免疫系统的影响[J]. 山东大学学报 (医学版), 2019, 57(2): 11-15.

SHI Yuhua, ZHENG Qingmei. Effects of climacteric and menopausal hormone therapy on immune system[J]. Journal of Shandong University (Health Sciences), 2019, 57(2): 11-15.

参考文献

[1] 谢梅青, 陈蓉, 任慕兰. 中国绝经管理与绝经激素治疗指南(2018)[J]. 协和医学杂志, 2018, 9(6): 512-525.
[2] Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop+10: addressing the unfinished agenda of staging reproductive aging[J]. J Clin Endocrinol Metab, 2012, 97(4): 1159-1168.
[3] 于爱莲, 王月丹. 病原生物学与免疫学[M]. 北京:北京大学医学出版社, 2015.
[4] Bodey B, Bodey B Jr, Siegel SE, et al. Molecular biological ontogenesis of the thymic reticulo-epithelial cell network during the organization of the cellular microenvironment[J]. In Vivo, 1999, 13(3): 267-294.
[5] Grimaldi CM, Hill L, Xu XN, et al. Hormonal modulation of B cell development and repertoire selection[J]. Mol Immunol, 2005, 42(7): 811-820.
[6] Medina KL, Strasser A, Kincade PW. Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors[J]. Blood, 2000, 95(6): 2059-2067.
[7] Franceschi C, Monti D, Barbieri D, et al. Immunosenescence in humans: deterioration or remodelling?[J]. Int Rev Immunol, 1995, 12(1): 57-74.
[8] Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants[J]. Science, 2002, 295(5562): 2097-2100.
[9] Rubnitz JE, Inaba H, Ribeiro RC, et al. NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia[J]. J Clin Oncol, 2010, 28(6): 955-959.
[10] Borrego F, Alonso MC, Galiani MD, et al. NK phenotypic markers and IL2 response in NK cells from elderly people[J]. Exp Gerontol, 1999, 34(2): 253-265.
[11] Kutza J, Murasko DM. Age-associated decline in IL-2 and IL-12 induction of LAK cell activity of human PBMC samples[J]. Mech Ageing Dev, 1996, 90(3): 209-222.
[12] 崔红旺, 孟志斌, 王挺锐, 等. 雌激素缺乏上调TNF-α促发卵巢切除大鼠骨细胞程序性坏死[J]. 中国骨质疏松杂志, 2017, 23(11): 1431-1437. CUI Hongwang, MENG Zhibin, WANG Tingrui, et al. Estrogen deficiency promotes osteocyte necroptosis in OVX rats by up-regulating TNF-α[J]. Chinese Journal of Osteoporosis, 2017, 23(11): 1431-1437.
[13] Cutolo M, Montagna P, Brizzolara R, et al. Sex hormones modulate the effects of Leflunomide on cytokine production by cultures of differentiated monocyte/macrophages and synovial macrophages from rheumatoid arthritis patients[J]. J Autoimmun, 2009, 32(3/4): 254-260.
[14] Lio D, Balistreri CR, Candore G, et al. In vitro treatment with interleukin-2 normalizes type-1 cytokine production by lymphocytes from elderly[J]. Immunopharmacol Immunotoxicol, 2000, 22(2): 195-203.
[15] Kim OY, Chae JS, Paik JK, et al. Effects of aging and menopause on serum interleukin-6 levels and peripheral blood mononuclear cell cytokine production in healthy nonobese women[J]. Age(Dordr), 2012, 34(2): 415-425.
[16] Berg G, Ekerfelt C, Hammar M, et al. Cytokine changes in postmenopausal women treated with estrogens: a placebo-controlled study[J]. Am J Reprod Immunol, 2002, 48(2): 63-69.
[17] Verma P, Verma R, Nair RR, et al. Altered crosstalk of estradiol and progesterone with Myeloid derived suppressor cells and Th1/Th2 cytokines in early miscarriage is associated with early breakdown of maternal-fetal tolerance[J]. Am J Reprod Immunol, 2018: e13081. doi: 10.1111/aji.13081.
[18] Salem ML. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production[J]. Curr Drug Targets Inflamm Allergy, 2004, 3(1): 97-104.
[19] Kamada M, Irahara M, Maegawa M, et al. Transient increase in the levels of T-helper 1 cytokines in postmenopausal women and the effects of hormone replacement therapy[J]. Gynecol Obstet Invest, 2001, 52(2): 82-88.
[20] 卢寨娥, 蒋竞. 雌激素治疗对绝经妇女Th1/Th2平衡的影响[J]. 浙江医学, 2014, 36(2): 118-119,123. LU Zhaie, JIANG Jing. Effects of estrogen therapy on the Th1/Th2 balance in postmenopausal women[J]. Zhejiang Medical Journal, 2014, 36(2): 118-119,123.
[21] Kumru S, Godekmerdan A, Yilmaz B. Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women[J]. J Reprod Immunol, 2004, 63(1): 31-38.
[22] Porter VR, Greendale GA, Schocken M, et al. Immune effects of hormone replacement therapy in post-menopausal women[J]. Exp Gerontol, 2001, 36(2): 311-326.
[23] Tani AN, Yasui T, Matsui S, et al. Different circulating levels of monocyte chemoattractant protein-1 and interleukin-8 during the menopausal transition[J]. Cytokine, 2013, 62(1): 86-90.
[24] Koh KK, Son JW, Ahn JY, et al. Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels[J]. Int J Cardiol, 2001, 81(1): 43-50.
[25] Miyatani Y, Yasui T, Uemura H, et al. Associations of circulating adiponectin with estradiol and monocyte chemotactic protein-1 in postmenopausal women[J]. Menopause, 2008, 15(3): 536-541.
[26] Ghosh M, Rodriguez-Garcia M, Wira CR. The immune system in menopause: pros and cons of hormone therapy[J]. J Steroid Biochem Mol Biol, 2014, 142:171-175. doi: 10.1016/j.jsbmb.2013.09.003.
[27] de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised global consensus statement on menopausal hormone therapy[J]. Climacteric, 2016, 19(4): 313-315.
[28] Baber RJ, Panay N, Fenton A, et al. 2016 IMS Recommendations on womens midlife health and menopause hormone therapy[J]. Climacteric, 2016, 19(2): 109-150.

相关文章 15

[1]	孙佳丽,王亮,王长凤,张杰,郭磊. Klippel-Trenaunay综合征儿童情绪与行为特征及其影响因素[J]. 山东大学学报 (医学版), 2026, 64(3): 78-82.
[2]	宋一鸣,王佳丰,韩晓娟,杜怡峰. 脑维持与认知功能:测量、影响因素和机制[J]. 山东大学学报 (医学版), 2026, 64(1): 1-7.
[3]	徐欣颖,颜伟,石兴龙,岳芳,吕婧,乔颖异,张宇琦,程传龙,左慧,李秀君. 山东省滨州市手足口病的流行特征及影响因素[J]. 山东大学学报 (医学版), 2026, 64(1): 118-125.
[4]	孙爽爽,仉率杰,张伯韬,袁莹,于媛媛,薛付忠. 基于真实世界研究的18~50岁人群急性缺血性卒中影响因素[J]. 山东大学学报 (医学版), 2025, 63(9): 40-46.
[5]	王宁,郝秀梅,牛翔,黄金明,徐静雅. 中国中老年高血糖、血脂异常、高血压人群健康体检服务利用现状及影响因素[J]. 山东大学学报 (医学版), 2025, 63(7): 82-91.
[6]	张永媛,王清亮,连雪洪. 山东省某三级综合医院罕见病患者住院费用结构变动情况及影响因素[J]. 山东大学学报 (医学版), 2025, 63(5): 111-119.
[7]	陈瑛翼,游倩,王意,张帆,李凤,季舒铭,徐浩源,饶志勇. 办公室职员肌肉质量减少预测模型的开发与验证[J]. 山东大学学报 (医学版), 2025, 63(4): 26-35.
[8]	刘国伟,翟艳,王薇,吕军城. 潍坊市某城区65岁及以上老年人社会适应能力现状及其影响因素[J]. 山东大学学报 (医学版), 2025, 63(2): 104-110.
[9]	穆弘杰,卢伟,吕军城. 居民抑郁、焦虑症状和心理健康素养现况及影响因素分析[J]. 山东大学学报 (医学版), 2025, 63(12): 105-111.
[10]	赵书睿,赵烨. 围绝经期及绝经后期子宫内膜异位症的诊疗现状[J]. 山东大学学报 (医学版), 2025, 63(10): 20-26.
[11]	刘峰,马彩霞,李春燕,程海英,靳乐雨,刘仲,李学文. 2023年11月流感高峰期济南市大学生流感样病例发生情况及影响因素[J]. 山东大学学报 (医学版), 2024, 62(7): 91-97.
[12]	景睿,张文茜,董卉,董怡然,于胜男,段勇,闫芹,赵传禄,李秀君,汪卫兵. 济南市大一新生结核病防治知信行现状及行为影响因素[J]. 山东大学学报 (医学版), 2024, 62(2): 101-107.
[13]	冯绪强,高萍,孙超,陶琳,闫根全,冷冰. 替加环素治疗感染性疾病临床疗效及影响因素[J]. 山东大学学报 (医学版), 2024, 62(12): 11-20.
[14]	于菲萍,李鑫,司明舒,张丹,苏永刚. 医学生医养结合认知程度与养老就业意愿[J]. 山东大学学报 (医学版), 2024, 62(11): 105-114.
[15]	刘凤祺,高峰,薛彩彩,乔秀梅,王金红. 高糖诱导PC12细胞损伤的影响因素及梓醇的保护作用[J]. 山东大学学报 (医学版), 2023, 61(7): 34-39.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed